Patent 11285005 was granted and assigned to Cardiac Dimensions on March, 2022 by the United States Patent and Trademark Office.
Methods of minimally-invasively treating mitral valve regurgitation. The methods include advancing a device in a collapsed configuration into a coronary sinus, causing a distal anchor of the device to expand, exposing a connecting member of the device, pulling proximally on the device, causing a proximal anchor of the device to expand, and releasing the device.